Therapeutic targets in the ASK1-dependent stress signaling pathways

DOI 機関リポジトリ HANDLE Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献6件 参考文献82件
  • HAYAKAWA Ryoichi
    Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo
  • HAYAKAWA Teruyuki
    Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo
  • TAKEDA Kohsuke
    Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo Division of Cell Regulation, Graduate School of Biomedical Sciences, Nagasaki University
  • ICHIJO Hidenori
    Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo

この論文をさがす

抄録

Apoptosis signal-regulating kinase 1 (ASK1) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family that activates downstream MAP kinases (MAPKs), c-Jun N-terminal kinases (JNKs) and p38 MAPKs, in response to various stresses, such as reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, lipopolysaccharide, and calcium overload. Activation of the JNK and p38 pathways induces stress responses such as cell death, differentiation, and the production of inflammatory cytokines. A series of studies using ASK1-deficient mice have indicated that ASK1 plays important roles in many stress-related diseases, including cardiovascular and neurodegenerative diseases, suggesting that small compounds that inhibit ASK1 activity could possibly be used for the amelioration of the development and/or progression of these diseases. In this review, we provide an overview of the pathophysiological roles of ASK1-dependent signaling pathways and discuss the mechanistic basis for how these could serve as potential therapeutic targets.<BR><BR>(Communicated by Takao SEKIYA, M.J.A.)

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (82)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ